Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Continuous Wound Infiltration with Ropivacaine in Hallux Valgus Surgery
NCT02182999Phase 4Completed
- Sponsor
- Medical University of Innsbruck
- Start
- May 2014
- Primary completion
- Apr 2017
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of ropivacaine in postoperative pain, sponsored by Medical University of Innsbruck. Started May 2014; status: completed.
02
Drugs
ropivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT02182999.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02182999.